Differentiation of hypervirulent and classical Klebsiella pneumoniae with acquired drug resistance
mBio · 14.02.2024 · 15 (2)
DOI: 10.1128/mbio.02867-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, erschienen am 14.02.2024. Verfasst von Thomas A Russo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Veterans Administration Western New York Healthcare System, University at Buffalo, Buffalo, New York, USA. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections. Die Arbeit wurde bisher 159-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIAID NIH HHS, HHS | National Institutes of Health.
Abstract (Originalsprache)
Hypervirulent Klebsiella pneumoniae (hvKp) is a concerning pathogen that can cause life-threatening infections in otherwise healthy individuals. Importantly, although strains of hvKp have been acquiring antimicrobial resistance, the effect on virulence is unclear. Therefore, it is of critical importance to determine whether a given antimicrobial resistant K. pneumoniae isolate is hypervirulent. This report determined which combination of genotypic and phenotypic markers could most accurately identify hvKp strains with acquired resistance. Both logistic regression and a machine-learning prediction model demonstrated that biomarker count alone was the strongest predictor. The presence of all five of the biomarkers iucA, iroB, peg-344, rmpA, and rmpA2 was most accurate (94%); the presence of ≥4 of these biomarkers was most sensitive (100%). Accurately identifying hvKp is vital for surveillance and research, and the availability of biomarker data could alert the clinician that hvKp is a consideration, which, in turn, would assist in optimizing patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Veterans Administration Western New York Healthcare System, University at Buffalo, Buffalo, New York, USA.
- Department of Medicine, University at Buffalo, Buffalo, New York, USA.
- Department of Microbiology and Immunology, University at Buffalo, Buffalo, New York, USA.
- The Witebsky Center for Microbial Pathogenesis, University at Buffalo, State University of New York, Buffalo, New York, USA.
- Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
- Multidrug-Resistant Organism Repository and Surveillance Network (MRSN), Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
ORCID-Profile: Thomas A Russo, Alison L Halpin, Patrick T McGann, Francois Lebreton
Förderung
- BLRD VA
- NIAID NIH HHS
- HHS | National Institutes of Health
- Veterans Administration Medical Center
- DOD | USA | U.S. Army Medical Command
- Defense Medical Research and Development Program
Zitieren
APA
Russo, T. A., Alvarado, C. L., Davies, C. J., Drayer, Z. J., Carlino-MacDonald, U., Hutson, A., Luo, T. L., Martin, M. J., Corey, B. W., Moser, K. A., Rasheed, J. K., Halpin, A. L., McGann, P. T., & Lebreton, F. (2024). Differentiation of hypervirulent and classical Klebsiella pneumoniae with acquired drug resistance. mBio, 15(2). https://doi.org/10.1128/mbio.02867-23
Vancouver
Russo TA, Alvarado CL, Davies CJ, Drayer ZJ, Carlino-MacDonald U, Hutson A, et al. Differentiation of hypervirulent and classical Klebsiella pneumoniae with acquired drug resistance. mBio. 2024;15(2). doi:10.1128/mbio.02867-23
BibTeX
@article{Russo2024,
author = {Russo, Thomas A and Alvarado, Cassandra L and Davies, Connor J and Drayer, Zachary J and Carlino-MacDonald, Ulrike and Hutson, Alan and Luo, Ting L and Martin, Melissa J and Corey, Brendan W and Moser, Kara A and Rasheed, J Kamile and Halpin, Alison L and McGann, Patrick T and Lebreton, Francois},
title = {Differentiation of hypervirulent and classical Klebsiella pneumoniae with acquired drug resistance},
journal = {mBio},
year = {2024},
volume = {15},
number = {2},
doi = {10.1128/mbio.02867-23}
}
EUVIMED